{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:29:43Z","timestamp":1791286183954,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD106285"],"award-info":[{"award-number":["R01HD106285"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD087417"],"award-info":[{"award-number":["R01HD087417"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00109-025-02517-0","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T13:34:13Z","timestamp":1738676053000},"page":"311-326","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mediator kinase inhibition drives myometrial stem cell differentiation and the uterine fibroid phenotype through super-enhancer reprogramming"],"prefix":"10.1007","volume":"103","author":[{"given":"Subash","family":"Khadka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire Xin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sribalashubashini","family":"Muralimanoharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthigayan","family":"Shanmugasundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azad","family":"Khosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Barron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Schenken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Stansbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schenken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Firestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9164-8712","authenticated-orcid":false,"given":"Thomas G.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"2517_CR1","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1177\/1933719114533728","volume":"21","author":"L Doherty","year":"2014","unstructured":"Doherty L, Mutlu L, Sinclair D, Taylor H (2014) Uterine fibroids: clinical manifestations and contemporary management. Reprod Sci 21:1067\u20131092. https:\/\/doi.org\/10.1177\/1933719114533728","journal-title":"Reprod Sci"},{"key":"2517_CR2","doi-asserted-by":"publisher","first-page":"16043","DOI":"10.1038\/nrdp.2016.43","volume":"2","author":"EA Stewart","year":"2016","unstructured":"Stewart EA, Laughlin-Tommaso SK, Catherino WH, Lalitkumar S, Gupta D, Vollenhoven B (2016) Uterine fibroids. Nat Rev Dis Prim 2:16043. https:\/\/doi.org\/10.1038\/nrdp.2016.43","journal-title":"Nat Rev Dis Prim"},{"key":"2517_CR3","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1056\/NEJMra1209993","volume":"369","author":"SE Bulun","year":"2013","unstructured":"Bulun SE (2013) Uterine fibroids. N Engl J Med 369:1344\u20131355. https:\/\/doi.org\/10.1056\/NEJMra1209993","journal-title":"N Engl J Med"},{"key":"2517_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/grf.0000000000000171","volume":"59","author":"CB Bartels","year":"2016","unstructured":"Bartels CB, Cayton KC, Chuong FS, Holthouser K, Arian SE, Abraham T, Segars JH (2016) An evidence-based approach to the medical management of fibroids: a systematic review. Clin Obstet Gynecol 59:30\u201352. https:\/\/doi.org\/10.1097\/grf.0000000000000171","journal-title":"Clin Obstet Gynecol"},{"key":"2517_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ijgo.13102","volume":"149","author":"E Giuliani","year":"2020","unstructured":"Giuliani E, As-Sanie S, Marsh EE (2020) Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet 149:3\u20139. https:\/\/doi.org\/10.1002\/ijgo.13102","journal-title":"Int J Gynaecol Obstet"},{"key":"2517_CR6","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1080\/14656566.2023.2248890","volume":"24","author":"M Ciebiera","year":"2023","unstructured":"Ciebiera M, Madueke-Laveaux OS, Feduniw S, Ulin M, Spaczy\u0144ski R, Zgliczy\u0144ska M, B\u0105czkowska M, Zarychta E, \u0141ozi\u0144ski T, Ali M et al (2023) GnRH agonists and antagonists in therapy of symptomatic uterine fibroids \u2013 current roles and future perspectives. Expert Opin Pharmacother 24:1799\u20131809. https:\/\/doi.org\/10.1080\/14656566.2023.2248890","journal-title":"Expert Opin Pharmacother"},{"key":"2517_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1055\/s-0037-1607205","volume":"35","author":"H Elkafas","year":"2017","unstructured":"Elkafas H, Qiwei Y, Al-Hendy A (2017) Origin of uterine fibroids: conversion of myometrial stem cells to tumor-initiating cells. Semin Reprod Med 35:481\u2013486. https:\/\/doi.org\/10.1055\/s-0037-1607205","journal-title":"Semin Reprod Med"},{"key":"2517_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1126\/science.1208930","volume":"334","author":"N M\u00e4kinen","year":"2011","unstructured":"M\u00e4kinen N, Mehine M, Tolvanen J, Kaasinen E, Li Y, Lehtonen HJ, Gentile M, Yan J, Enge M, Taipale M et al (2011) MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 334:252\u2013255. https:\/\/doi.org\/10.1126\/science.1208930","journal-title":"Science"},{"key":"2517_CR9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41586-021-03747-1","volume":"596","author":"DG Berta","year":"2021","unstructured":"Berta DG, Kuisma H, V\u00e4lim\u00e4ki N, R\u00e4is\u00e4nen M, J\u00e4ntti M, Pasanen A, Karhu A, Kaukomaa J, Taira A, Cajuso T et al (2021) Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma. Nature 596:398\u2013403. https:\/\/doi.org\/10.1038\/s41586-021-03747-1","journal-title":"Nature"},{"key":"2517_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1056\/NEJMoa1302736","volume":"369","author":"M Mehine","year":"2013","unstructured":"Mehine M, Kaasinen E, Makinen N, Katainen R, Kampjarvi K, Pitkanen E, Heinonen HR, Butzow R, Kilpivaara O, Kuosmanen A et al (2013) Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med 369:43\u201353. https:\/\/doi.org\/10.1056\/NEJMoa1302736","journal-title":"N Engl J Med"},{"key":"2517_CR11","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/humu.22612","volume":"35","author":"K Kampjarvi","year":"2014","unstructured":"Kampjarvi K, Park MJ, Mehine M, Kim NH, Clark AD, Butzow R, Bohling T, Bohm J, Mecklin JP, Jarvinen H et al (2014) Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas. Hum Mutat 35:1136\u20131141. https:\/\/doi.org\/10.1002\/humu.22612","journal-title":"Hum Mutat"},{"key":"2517_CR12","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1172\/jci81534","volume":"125","author":"P Mittal","year":"2015","unstructured":"Mittal P, Shin YH, Yatsenko SA, Castro CA, Surti U, Rajkovic A (2015) Med12 gain-of-function mutation causes leiomyomas and genomic instability. J Clin Invest 125:3280\u20133284. https:\/\/doi.org\/10.1172\/jci81534","journal-title":"J Clin Invest"},{"key":"2517_CR13","doi-asserted-by":"publisher","first-page":"eabd4484","DOI":"10.1126\/sciadv.abd4484","volume":"7","author":"Y-C Li","year":"2021","unstructured":"Li Y-C, Chao T-C, Kim HJ, Cholko T, Chen S-F, Li G, Snyder L, Nakanishi K, Chang C-e, Murakami K et al (2021) Structure and noncanonical Cdk8 activation mechanism within an Argonaute-containing Mediator kinase module. Sci Adv 7:eabd4484. https:\/\/doi.org\/10.1126\/sciadv.abd4484","journal-title":"Sci Adv"},{"key":"2517_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3109\/10409238.2015.1064854","volume":"50","author":"AD Clark","year":"2015","unstructured":"Clark AD, Oldenbroek M, Boyer TG (2015) Mediator kinase module and human tumorigenesis. Crit Rev Biochem Mol Biol 50:393\u2013426. https:\/\/doi.org\/10.3109\/10409238.2015.1064854","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"2517_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmb.2011.07.020","volume":"412","author":"EV Schneider","year":"2011","unstructured":"Schneider EV, Bottcher J, Blaesse M, Neumann L, Huber R, Maskos K (2011) The structure of CDK8\/CycC implicates specificity in the CDK\/cyclin family and reveals interaction with a deep pocket binder. J Mol Biol 412:251\u2013266. https:\/\/doi.org\/10.1016\/j.jmb.2011.07.020","journal-title":"J Mol Biol"},{"key":"2517_CR16","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.celrep.2014.03.047","volume":"7","author":"M Turunen","year":"2014","unstructured":"Turunen M, Spaeth JM, Keskitalo S, Park MJ, Kivioja T, Clark AD, M\u00e4kinen N, Gao F, Palin K, Nurkkala H et al (2014) Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity. Cell Rep 7:654\u2013660. https:\/\/doi.org\/10.1016\/j.celrep.2014.03.047","journal-title":"Cell Rep"},{"key":"2517_CR17","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.1074\/jbc.RA118.001725","volume":"293","author":"MJ Park","year":"2018","unstructured":"Park MJ, Shen H, Spaeth JM, Tolvanen JH, Failor C, Knudtson JF, McLaughlin J, Halder SK, Yang Q, Bulun SE et al (2018) Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8\/19. J Biol Chem 293:4870\u20134882. https:\/\/doi.org\/10.1074\/jbc.RA118.001725","journal-title":"J Biol Chem"},{"key":"2517_CR18","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1128\/MCB.00993-08","volume":"29","author":"MT Knuesel","year":"2009","unstructured":"Knuesel MT, Meyer KD, Donner AJ, Espinosa JM, Taatjes DJ (2009) The human CDK8 subcomplex is a histone kinase that requires Med12 for activity and can function independently of mediator. Mol Cell Biol 29:650\u2013661. https:\/\/doi.org\/10.1128\/MCB.00993-08","journal-title":"Mol Cell Biol"},{"key":"2517_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/pros.23092","volume":"76","author":"K Kampjarvi","year":"2016","unstructured":"Kampjarvi K, Kim NH, Keskitalo S, Clark AD, von Nandelstadh P, Turunen M, Heikkinen T, Park MJ, Makinen N, Kivinummi K et al (2016) Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms. Prostate 76:22\u201331. https:\/\/doi.org\/10.1002\/pros.23092","journal-title":"Prostate"},{"key":"2517_CR20","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1210\/jc.2018-00863","volume":"103","author":"MJ Park","year":"2018","unstructured":"Park MJ, Shen H, Kim NH, Gao F, Failor C, Knudtson JF, McLaughlin J, Halder SK, Heikkinen TA, Vahteristo P et al (2018) Mediator kinase disruption in MED12-mutant uterine fibroids from hispanic women of South Texas. J Clin Endocrinol Metab 103:4283\u20134292. https:\/\/doi.org\/10.1210\/jc.2018-00863","journal-title":"J Clin Endocrinol Metab"},{"key":"2517_CR21","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1016\/j.molcel.2024.09.001","volume":"84","author":"T-C Chao","year":"2024","unstructured":"Chao T-C, Chen S-F, Kim HJ, Tang H-C, Tseng H-C, Xu A, Palao L III, Khadka S, Li T, Huang M-F et al (2024) Structural basis of the human transcriptional Mediator regulated by its dissociable kinase module. Mol Cell 84:3932-3949.e3910. https:\/\/doi.org\/10.1016\/j.molcel.2024.09.001","journal-title":"Mol Cell"},{"key":"2517_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.fertnstert.2015.04.021","volume":"104","author":"A Mas","year":"2015","unstructured":"Mas A, Nair S, Laknaur A, Simon C, Diamond MP, Al-Hendy A (2015) Stro-1\/CD44 as putative human myometrial and fibroid stem cell markers. Fertil Steril 104:225-234.e223. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.04.021","journal-title":"Fertil Steril"},{"key":"2517_CR23","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.fertnstert.2012.04.044","volume":"98","author":"A Mas","year":"2012","unstructured":"Mas A, Cervello I, Gil-Sanchis C, Faus A, Ferro J, Pellicer A, Simon C (2012) Identification and characterization of the human leiomyoma side population as putative tumor-initiating cells. Fertil Steril 98:741-751.e746. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.04.044","journal-title":"Fertil Steril"},{"key":"2517_CR24","doi-asserted-by":"publisher","first-page":"E601","DOI":"10.1210\/jc.2014-2134","volume":"100","author":"P Yin","year":"2015","unstructured":"Yin P, Ono M, Moravek MB, Coon JST, Navarro A, Monsivais D, Dyson MT, Druschitz SA, Malpani SS, Serna VA et al (2015) Human uterine leiomyoma stem\/progenitor cells expressing CD34 and CD49b initiate tumors in vivo. J Clin Endocrinol Metab 100:E601-606. https:\/\/doi.org\/10.1210\/jc.2014-2134","journal-title":"J Clin Endocrinol Metab"},{"key":"2517_CR25","doi-asserted-by":"publisher","first-page":"18700","DOI":"10.1073\/pnas.0704472104","volume":"104","author":"M Ono","year":"2007","unstructured":"Ono M, Maruyama T, Masuda H, Kajitani T, Nagashima T, Arase T, Ito M, Ohta K, Uchida H, Asada H et al (2007) Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells. Proc Natl Acad Sci 104:18700\u201318705. https:\/\/doi.org\/10.1073\/pnas.0704472104","journal-title":"Proc Natl Acad Sci"},{"key":"2517_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1095\/biolreprod.114.127126","volume":"93","author":"M Ono","year":"2015","unstructured":"Ono M, Kajitani T, Uchida H, Arase T, Oda H, Uchida S, Ota K, Nagashima T, Masuda H, Miyazaki K et al (2015) CD34 and CD49f Double-positive and lineage marker-negative cells isolated from human myometrium exhibit stem cell-like properties involved in pregnancy-induced uterine remodeling. Biol Reprod 93:37. https:\/\/doi.org\/10.1095\/biolreprod.114.127126","journal-title":"Biol Reprod"},{"key":"2517_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/humrep\/dez247","volume":"35","author":"AL Patterson","year":"2020","unstructured":"Patterson AL, George JW, Chatterjee A, Carpenter TJ, Wolfrum E, Chesla DW, Teixeira JM (2020) Putative human myometrial and fibroid stem-like cells have mesenchymal stem cell and endometrial stromal cell properties. Hum Reprod 35:44\u201357. https:\/\/doi.org\/10.1093\/humrep\/dez247","journal-title":"Hum Reprod"},{"key":"2517_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.xfss.2021.09.003","volume":"2","author":"L Barron","year":"2021","unstructured":"Barron L, Khadka S, Schenken R, He L, Blenis J, Blagg J, Chen SF, Tsai KL, Boyer TG (2021) Identification and characterization of the mediator kinase-dependent myometrial stem cell phosphoproteome. F S Sci 2:383\u2013395. https:\/\/doi.org\/10.1016\/j.xfss.2021.09.003","journal-title":"F S Sci"},{"key":"2517_CR29","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1021\/jm501436m","volume":"58","author":"A Mallinger","year":"2015","unstructured":"Mallinger A, Crumpler S, Pichowicz M, Waalboer D, Stubbs M, Adeniji-Popoola O, Wood B, Smith E, Thai C, Henley AT et al (2015) Discovery of potent, orally bioavailable, small-molecule inhibitors of WNT signaling from a cell-based pathway screen. J Med Chem 58:1717\u20131735. https:\/\/doi.org\/10.1021\/jm501436m","journal-title":"J Med Chem"},{"key":"2517_CR30","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nchembio.1952","volume":"11","author":"T Dale","year":"2015","unstructured":"Dale T, Clarke PA, Esdar C, Waalboer D, Adeniji-Popoola O, Ortiz-Ruiz MJ, Mallinger A, Samant RS, Czodrowski P, Musil D et al (2015) A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease. Nat Chem Biol 11:973\u2013980. https:\/\/doi.org\/10.1038\/nchembio.1952","journal-title":"Nat Chem Biol"},{"key":"2517_CR31","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1248\/cpb.c24-00392","volume":"72","author":"K Morishita","year":"2024","unstructured":"Morishita K, Yamamoto M, Takashima S, Ando M, Kawai S, Otake K, Shoji Y, Hinoi E, Kitao T, Shirahase H (2024) Synthesis and evaluation of a novel series of diphenylamine and diphenylether derivatives with osteoblastogenic and osteogenic effects via CDK8 inhibition. Chem Pharm Bull (Tokyo) 72:862\u2013883. https:\/\/doi.org\/10.1248\/cpb.c24-00392","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"2517_CR32","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1248\/bpb.b23-00834","volume":"47","author":"M Yamamoto","year":"2024","unstructured":"Yamamoto M, Shibata Y, Ito Y, Fukui M, Kioka H, Shoji Y, Kitao T, Shirahase H, Hinoi E (2024) Osteoblastgenic and osteogenic effects of KY-273 with CDK8\/19 inhibitory activity in bone marrow mesenchymal stem cells and female rats. Biol Pharm Bull 47:669\u2013679. https:\/\/doi.org\/10.1248\/bpb.b23-00834","journal-title":"Biol Pharm Bull"},{"key":"2517_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-022-03220-4","volume":"14","author":"K Sakuma","year":"2023","unstructured":"Sakuma K, Tsubooka-Yamazoe N, Hashimoto K, Sakai N, Asano S, Watanabe-Matsumoto S, Watanabe T, Saito B, Matsumoto H, Ueno H et al (2023) CDK8\/19 inhibition plays an important role in pancreatic \u03b2-cell induction from human iPSCs. Stem Cell Res Ther 14:1. https:\/\/doi.org\/10.1186\/s13287-022-03220-4","journal-title":"Stem Cell Res Ther"},{"key":"2517_CR34","doi-asserted-by":"publisher","unstructured":"Dannappel MV, Zhu D, Sun X, Chua HK, Poppelaars M, Suehiro M, Khadka S, Lim Kam Sian TC, Sooraj D, Loi M, et al (2022) CDK8 and CDK19 regulate intestinal differentiation and homeostasis via the chromatin remodeling complex SWI\/SNF. J Clin Invest 132. https:\/\/doi.org\/10.1172\/jci158593","DOI":"10.1172\/jci158593"},{"key":"2517_CR35","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.3389\/fimmu.2019.01988","volume":"10","author":"Z Guo","year":"2019","unstructured":"Guo Z, Wang G, Lv Y, Wan YY, Zheng J (2019) Inhibition of Cdk8\/Cdk19 activity promotes treg cell differentiation and suppresses autoimmune diseases. Front Immunol 10:1988. https:\/\/doi.org\/10.3389\/fimmu.2019.01988","journal-title":"Front Immunol"},{"key":"2517_CR36","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1158\/0008-5472.Can-11-3886","volume":"72","author":"AS Adler","year":"2012","unstructured":"Adler AS, McCleland ML, Truong T, Lau S, Modrusan Z, Soukup TM, Roose-Girma M, Blackwood EM, Firestein R (2012) CDK8 maintains tumor dedifferentiation and embryonic stem cell pluripotency. Cancer Res 72:2129\u20132139. https:\/\/doi.org\/10.1158\/0008-5472.Can-11-3886","journal-title":"Cancer Res"},{"key":"2517_CR37","doi-asserted-by":"publisher","unstructured":"Yang Q, Al-Hendy A (2023) Update on the role and regulatory mechanism of extracellular matrix in the pathogenesis of uterine fibroids. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms24065778","DOI":"10.3390\/ijms24065778"},{"key":"2517_CR38","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s41467-020-14701-6","volume":"11","author":"MB Moyo","year":"2020","unstructured":"Moyo MB, Parker JB, Chakravarti D (2020) Altered chromatin landscape and enhancer engagement underlie transcriptional dysregulation in MED12 mutant uterine leiomyomas. Nat Commun 11:1019. https:\/\/doi.org\/10.1038\/s41467-020-14701-6","journal-title":"Nat Commun"},{"key":"2517_CR39","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1038\/s41467-023-39684-y","volume":"14","author":"K Buyukcelebi","year":"2023","unstructured":"Buyukcelebi K, Chen X, Abdula F, Elkafas H, Duval AJ, Ozturk H, Seker-Polat F, Jin Q, Yin P, Feng Y et al (2023) Engineered MED12 mutations drive leiomyoma-like transcriptional and metabolic programs by altering the 3D genome compartmentalization. Nat Commun 14:4057. https:\/\/doi.org\/10.1038\/s41467-023-39684-y","journal-title":"Nat Commun"},{"key":"2517_CR40","doi-asserted-by":"publisher","unstructured":"Chen S-F, Chao T-C, Kim HJ, Tang H-C, Khadka S, Li T, Lee D-F, Murakami K, Boyer TG, Tsai K-L (2024) Structural basis of the human transcriptional Mediator complex modulated by its dissociable Kinase module. bioRxiv: 2024.2007.2001.601608. https:\/\/doi.org\/10.1101\/2024.07.01.601608","DOI":"10.1101\/2024.07.01.601608"},{"key":"2517_CR41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature07829","volume":"459","author":"ND Heintzman","year":"2009","unstructured":"Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, Ye Z, Lee LK, Stuart RK, Ching CW et al (2009) Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459:108\u2013112. https:\/\/doi.org\/10.1038\/nature07829","journal-title":"Nature"},{"key":"2517_CR42","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.molcel.2014.12.029","volume":"57","author":"HC Duttke Sascha","year":"2015","unstructured":"Duttke Sascha HC, Lacadie Scott A, Ibrahim Mahmoud M, Glass Christopher K, Corcoran David L, Benner C, Heinz S, Kadonaga James T, Ohler U (2015) Human promoters are intrinsically directional. Mol Cell 57:674\u2013684. https:\/\/doi.org\/10.1016\/j.molcel.2014.12.029","journal-title":"Mol Cell"},{"key":"2517_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112566","volume":"42","author":"J Li","year":"2023","unstructured":"Li J, Bai Y, Liu Y, Song Z, Yang Y, Zhao Y (2023) Transcriptome-based chemical screens identify CDK8 as a common barrier in multiple cell reprogramming systems. Cell Rep 42:112566. https:\/\/doi.org\/10.1016\/j.celrep.2023.112566","journal-title":"Cell Rep"},{"key":"2517_CR44","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","volume":"153","author":"WA Whyte","year":"2013","unstructured":"Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI, Young RA (2013) Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153:307\u2013319. https:\/\/doi.org\/10.1016\/j.cell.2013.03.035","journal-title":"Cell"},{"key":"2517_CR45","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s41556-020-0573-1","volume":"22","author":"CJ Lynch","year":"2020","unstructured":"Lynch CJ, Bernad R, Mart\u00ednez-Val A, Shahbazi MN, N\u00f3brega-Pereira S, Calvo I, Blanco-Aparicio C, Tarantino C, Garreta E, Richart-Gin\u00e9s L et al (2020) Global hyperactivation of enhancers stabilizes human and mouse naive pluripotency through inhibition of CDK8\/19 Mediator kinases. Nat Cell Biol 22:1223\u20131238. https:\/\/doi.org\/10.1038\/s41556-020-0573-1","journal-title":"Nat Cell Biol"},{"key":"2517_CR46","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nature14904","volume":"526","author":"HE Pelish","year":"2015","unstructured":"Pelish HE, Liau BB, Nitulescu II, Tangpeerachaikul A, Poss ZC, Da Silva DH, Caruso BT, Arefolov A, Fadeyi O, Christie AL et al (2015) Mediator kinase inhibition further activates super-enhancer-associated genes in AML. Nature 526:273\u2013276. https:\/\/doi.org\/10.1038\/nature14904","journal-title":"Nature"},{"key":"2517_CR47","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma\u2019ayan A (2013) Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14:128. https:\/\/doi.org\/10.1186\/1471-2105-14-128","journal-title":"BMC Bioinformatics"},{"key":"2517_CR48","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/jcp.1041330216","volume":"133","author":"H Von Koskull","year":"1987","unstructured":"Von Koskull H, Virtanen I (1987) Induction of cytokeratin expression in human mesenchymal cells. J Cell Physiol 133:321\u2013329. https:\/\/doi.org\/10.1002\/jcp.1041330216","journal-title":"J Cell Physiol"},{"key":"2517_CR49","doi-asserted-by":"publisher","first-page":"13141","DOI":"10.1002\/jcb.28589","volume":"120","author":"JF dos Santos","year":"2019","unstructured":"dos Santos JF, Bor\u00e7ari NR, da Silva AM, Nunes VA (2019) Mesenchymal stem cells differentiate into keratinocytes and express epidermal kallikreins: towards an in vitro model of human epidermis. J Cell Biochem 120:13141\u201313155. https:\/\/doi.org\/10.1002\/jcb.28589","journal-title":"J Cell Biochem"},{"key":"2517_CR50","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1038\/s41467-021-22181-5","volume":"12","author":"A Martinez-Val","year":"2021","unstructured":"Martinez-Val A, Lynch CJ, Calvo I, Xim\u00e9nez-Emb\u00fan P, Garcia F, Zarzuela E, Serrano M, Munoz J (2021) Dissection of two routes to na\u00efve pluripotency using different kinase inhibitors. Nat Commun 12:1863. https:\/\/doi.org\/10.1038\/s41467-021-22181-5","journal-title":"Nat Commun"},{"key":"2517_CR51","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.xfss.2024.07.006","volume":"5","author":"EN Paul","year":"2024","unstructured":"Paul EN, Carpenter TJ, Pavliscak LA, Bennett AZ, Ochoa-Bernal MA, Fazleabas AT, Teixeira JM (2024) HMGA2 overexpression induces plasticity in myometrial cells and a transcriptomic profile more similar to that of uterine fibroids. F S Sci 5:369\u2013378. https:\/\/doi.org\/10.1016\/j.xfss.2024.07.006","journal-title":"F S Sci"},{"key":"2517_CR52","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.xfss.2024.07.008","volume":"5","author":"P Saini","year":"2024","unstructured":"Saini P, Holmes AG, Wei JJ, Parker JB, Chakravarti D (2024) Engineered uterine primary myometrial cells with high-mobility group AT-hook 2 overexpression display a leiomyoma-like transcriptional and epigenomic phenotype. F S Sci 5:352\u2013368. https:\/\/doi.org\/10.1016\/j.xfss.2024.07.008","journal-title":"F S Sci"},{"key":"2517_CR53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.7555\/jbr.29.20140151","volume":"29","author":"JM Miano","year":"2015","unstructured":"Miano JM (2015) Myocardin in biology and disease. J Biomed Res 29:3\u201319. https:\/\/doi.org\/10.7555\/jbr.29.20140151","journal-title":"J Biomed Res"},{"key":"2517_CR54","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","volume":"168","author":"JE Bradner","year":"2017","unstructured":"Bradner JE, Hnisz D, Young RA (2017) Transcriptional addiction in cancer. Cell 168:629\u2013643. https:\/\/doi.org\/10.1016\/j.cell.2016.12.013","journal-title":"Cell"},{"key":"2517_CR55","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.molcel.2015.02.014","volume":"58","author":"D Hnisz","year":"2015","unstructured":"Hnisz D, Schuijers J, Lin CY, Weintraub AS, Abraham BJ, Lee TI, Bradner JE, Young RA (2015) Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Mol Cell 58:362\u2013370. https:\/\/doi.org\/10.1016\/j.molcel.2015.02.014","journal-title":"Mol Cell"},{"key":"2517_CR56","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ncponc0558","volume":"3","author":"IB Weinstein","year":"2006","unstructured":"Weinstein IB, Joe AK (2006) Mechanisms of disease: oncogene addiction\u2013a rationale for molecular targeting in cancer therapy. Nat Clin Pract Oncol 3:448\u2013457. https:\/\/doi.org\/10.1038\/ncponc0558","journal-title":"Nat Clin Pract Oncol"},{"key":"2517_CR57","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1469-7580.2009.01066.x","volume":"214","author":"HH Bragulla","year":"2009","unstructured":"Bragulla HH, Homberger DG (2009) Structure and functions of keratin proteins in simple, stratified, keratinized and cornified epithelia. J Anat 214:516\u2013559. https:\/\/doi.org\/10.1111\/j.1469-7580.2009.01066.x","journal-title":"J Anat"},{"key":"2517_CR58","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00418-008-0435-6","volume":"129","author":"R Moll","year":"2008","unstructured":"Moll R, Divo M, Langbein L (2008) The human keratins: biology and pathology. Histochem Cell Biol 129:705\u2013733. https:\/\/doi.org\/10.1007\/s00418-008-0435-6","journal-title":"Histochem Cell Biol"},{"key":"2517_CR59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00404-008-0851-9","volume":"280","author":"S Kumar","year":"2009","unstructured":"Kumar S, Shah JP, Bryant CS, Imudia AN, Ali-Fehmi R, Malone JM Jr, Morris RT (2009) Prognostic significance of keratinization in squamous cell cancer of uterine cervix: a population based study. Arch Gynecol Obstet 280:25\u201332. https:\/\/doi.org\/10.1007\/s00404-008-0851-9","journal-title":"Arch Gynecol Obstet"},{"key":"2517_CR60","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1016\/j.celrep.2019.11.077","volume":"29","author":"JW George","year":"2019","unstructured":"George JW, Fan H, Johnson B, Carpenter TJ, Foy KK, Chatterjee A, Patterson AL, Koeman J, Adams M, Madaj ZB et al (2019) Integrated epigenome, exome, and transcriptome analyses reveal molecular subtypes and homeotic transformation in uterine fibroids. Cell Rep 29:4069-4085.e4066. https:\/\/doi.org\/10.1016\/j.celrep.2019.11.077","journal-title":"Cell Rep"},{"key":"2517_CR61","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cell.2009.09.035","volume":"139","author":"C Alarc\u00f3n","year":"2009","unstructured":"Alarc\u00f3n C, Zaromytidou A-I, Xi Q, Gao S, Yu J, Fujisawa S, Barlas A, Miller AN, Manova-Todorova K, Macias MJ et al (2009) Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-\u03b2 pathways. Cell 139:757\u2013769. https:\/\/doi.org\/10.1016\/j.cell.2009.09.035","journal-title":"Cell"},{"key":"2517_CR62","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature07310","volume":"455","author":"EJ Morris","year":"2008","unstructured":"Morris EJ, Ji J-Y, Yang F, Di Stefano L, Herr A, Moon N-S, Kwon E-J, Haigis KM, N\u00e4\u00e4r AM, Dyson NJ (2008) E2F1 represses \u03b2-catenin transcription and is antagonized by both pRB and CDK8. Nature 455:552\u2013556. https:\/\/doi.org\/10.1038\/nature07310","journal-title":"Nature"},{"key":"2517_CR63","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/nprot.2018.015","volume":"13","author":"PJ Skene","year":"2018","unstructured":"Skene PJ, Henikoff JG, Henikoff S (2018) Targeted in situ genome-wide profiling with high efficiency for low cell numbers. Nat Protoc 13:1006\u20131019. https:\/\/doi.org\/10.1038\/nprot.2018.015","journal-title":"Nat Protoc"},{"key":"2517_CR64","doi-asserted-by":"publisher","first-page":"583","DOI":"10.21105\/joss.00583","volume":"3","author":"K Tsyganov","year":"2018","unstructured":"Tsyganov K, Perry AJ, Archer SK, Powell DR (2018) RNAsik: a pipeline for complete and reproducible RNA-seq analysis that runs anywhere with speed and ease. J Open Source Softw 3:583","journal-title":"J Open Source Softw"},{"key":"2517_CR65","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1371\/journal.pgen.0030161","volume":"3","author":"JT Leek","year":"2007","unstructured":"Leek JT, Storey JD (2007) Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet 3:e161. https:\/\/doi.org\/10.1371\/journal.pgen.0030161","journal-title":"PLoS Genet"},{"key":"2517_CR66","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13059-023-03027-3","volume":"24","author":"A Nordin","year":"2023","unstructured":"Nordin A, Zambanini G, Pagella P, Cant\u00f9 C (2023) The CUT&RUN suspect list of problematic regions of the genome. Genome Biol 24:185. https:\/\/doi.org\/10.1186\/s13059-023-03027-3","journal-title":"Genome Biol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02517-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-025-02517-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02517-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T02:14:18Z","timestamp":1741054458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-025-02517-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["2517"],"URL":"https:\/\/doi.org\/10.1007\/s00109-025-02517-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5125876\/v1","asserted-by":"object"}]},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The UT Health San Antonio Institutional Review Board approved the protocol for recovery of surgical specimens.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}